CXCL13



CXCL13

I1II1L2LL2E3EE3A4AA4H5HH5Y6YY6T7TT7N8NN8L9LL9K10KK10C11CC11R12RR12C13CC13S14SS14G15GG15V16VV16I17II17S18SS18T19TT19V20VV20V21VV21G22GG22L23LL23N24NN24I25II25I26II26D27DD27R28RR28I29II29Q30QQ30V31VV31T32TT32P33PP33P34PP34G35GG35N36NN36G37GG37C38CC38P39PP39K40KK40T41TT41E42EE42V43VV43V44VV44I45II45W46WW46T47TT47... and 41 more residue(s)...... and 41 more residue(s)

SMILES None
InChIKey None
Sequence ILEAHYTNLKCRCSGVISTVVGLNIIDRIQVTPPGNGCPKTEVVIWTKMKKVICVNPRAKWLQRLLRHVQSKSLSSTPQAPVSKRRAA

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL13

I1II1L2LL2E3EE3A4AA4H5HH5Y6YY6T7TT7N8NN8L9LL9K10KK10C11CC11R12RR12C13CC13S14SS14G15GG15V16VV16I17II17S18SS18T19TT19V20VV20V21VV21G22GG22L23LL23N24NN24I25II25I26II26D27DD27R28RR28I29II29Q30QQ30V31VV31T32TT32P33PP33P34PP34G35GG35N36NN36G37GG37C38CC38P39PP39K40KK40T41TT41E42EE42V43VV43V44VV44I45II45W46WW46T47TT47... and 41 more residue(s)...... and 41 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.